Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Feb-16 4:37 PM View:  | Chobotov Michael V. Chief Technology Officer | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 20,502 | $5.62 | $115,221.00 | (100%) 20.5K to 0 | (4%) |
| 05-Feb-16 2:04 PM View: | Roeder Douglas A Director 10% Owner | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 149 | -- | -- | (< 1%) 3.54M to 3.54M | |
| 04-Feb-16 4:43 PM View: | Moore Daniel Jeffrey Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 8,889 | -- | -- | (57%) 15.66K to 6.77K | |
| 04-Feb-16 4:42 PM View: | O'Quinn Shari L VP Clinical/Regulatory Affairs | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 29,597 | -- | -- | (58%) 51.24K to 21.64K | |
| 04-Feb-16 4:45 PM View: | Thomas Robert Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 16,523 | $2.43 | $40,150.90 | 18% 90.12K to 106.64K | |
| 04-Feb-16 4:40 PM View: | Elting Kimberley A. VP, Gen. Counsel and Secretary | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 76,621 | $2.61 | $200,268.00 | 1860% 4.12K to 80.74K | |
| 04-Feb-16 4:35 PM View: | Kramer Michael R Chief Financial Officer | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 31,032 | $1.26 | $38,957.80 | 34% 92.31K to 123.34K | |
| 04-Feb-16 4:41 PM View: | Jayaraman Vivek K VP Global Sales and Marketing | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 60,178 | $1.93 | $116,101.00 | 960% 6.27K to 66.45K | |
| 04-Feb-16 4:36 PM View: | Chavez Christopher G President, CEO and Chairman Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 113,323 | $0.85 | $96,590.00 | 17% 659.95K to 773.27K | |
| 05-Feb-16 2:04 PM View: | Delphi Management Partners ... 10% Owner | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition (change in control) | 3,535,910 | -- | -- | (100%) 3.54M to 0 | |
| 04-Feb-16 4:37 PM View: | Chobotov Michael V. Chief Technology Officer | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 34,537 | $1.56 | $53,792.90 | 20% 174.09K to 208.62K | |
| 04-Feb-16 4:43 PM View: | Moore Daniel Jeffrey Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 6,772 | $5.62 | $38,058.60 | (100%) 6.77K to 0 | (4%) |
| 04-Feb-16 4:42 PM View: | O'Quinn Shari L VP Clinical/Regulatory Affairs | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 21,641 | $5.62 | $121,622.00 | (100%) 21.64K to 0 | (4%) |
| 04-Feb-16 4:45 PM View: | Thomas Robert Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 99,494 | -- | -- | (93%) 106.64K to 7.14K | |
| 04-Feb-16 4:40 PM View: | Elting Kimberley A. VP, Gen. Counsel and Secretary | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 40,207 | -- | -- | (50%) 80.74K to 40.53K | |
| 04-Feb-16 4:35 PM View: | Kramer Michael R Chief Financial Officer | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 109,542 | -- | -- | (89%) 123.34K to 13.8K | |
| 04-Feb-16 4:41 PM View: | Jayaraman Vivek K VP Global Sales and Marketing | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 40,322 | -- | -- | (61%) 66.45K to 26.13K | |
| 04-Feb-16 4:36 PM View: | Chavez Christopher G President, CEO and Chairman Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 728,561 | -- | -- | (94%) 773.27K to 44.71K | |
| 04-Feb-16 4:37 PM View: | Chobotov Michael V. Chief Technology Officer | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 188,122 | -- | -- | (90%) 208.62K to 20.5K | |
| 05-Feb-16 2:04 PM View: | Roeder Douglas A Director 10% Owner | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition (change in control) Duplicate | 3,535,910 | -- | -- | (100%) 3.54M to 0 | |
| 04-Feb-16 1:26 PM View: | Scopa James Paul Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 1,776,690 | -- | -- | (100%) 1.78M to 0 | |
| 04-Feb-16 4:43 PM View: | Moore Daniel Jeffrey Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 15,661 | $2.43 | $38,056.20 | 100% 0 to 15.66K | |
| 04-Feb-16 4:42 PM View: | O'Quinn Shari L VP Clinical/Regulatory Affairs | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Option Exercise | 51,238 | $1.98 | $101,666.00 | 100% 0 to 51.24K | |
| 04-Feb-16 4:45 PM View: | Thomas Robert Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 7,145 | $5.62 | $40,154.90 | (100%) 7.14K to 0 | (4%) |
| 04-Feb-16 4:40 PM View: | Elting Kimberley A. VP, Gen. Counsel and Secretary | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 40,533 | $5.62 | $227,795.00 | (100%) 40.53K to 0 | (4%) |
| 04-Feb-16 4:35 PM View: | Kramer Michael R Chief Financial Officer | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 13,799 | $5.62 | $77,550.40 | (100%) 13.8K to 0 | (4%) |
| 04-Feb-16 4:41 PM View: | Jayaraman Vivek K VP Global Sales and Marketing | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 26,126 | $5.62 | $146,828.00 | (100%) 26.13K to 0 | (4%) |
| 04-Feb-16 4:36 PM View: | Chavez Christopher G President, CEO and Chairman Director | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Payment of Exercise | 44,714 | $5.62 | $251,293.00 | (100%) 44.71K to 0 | (4%) |
| 04-Feb-16 4:41 PM View: | New Enterprise Associates 1... 10% Owner | Trivascular Technologies, I... (TRIV) | 03-Feb-16 | Disposition | 3,943,270 | -- | -- | (100%) 3.94M to 0 | |
| 24-Apr-14 2:59 PM View: | Drant Ryan D Director 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion Duplicate | 3,359,940 | -- | -- | 100% 0 to 3.36M | |
| 22-Apr-14 5:16 PM View: | Flynn James E 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Purchase | 1,065,000 | $12.01 | $12,786,900.00 | 168% 632.67K to 1.7M | |
| 24-Apr-14 4:06 PM View: | Thomas Robert Director | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion | 78,562 | -- | -- | 396% 19.83K to 98.39K | |
| 24-Apr-14 2:58 PM View: | New Enterprise Associates 1... 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Purchase | 583,333 | $12.00 | $7,000,000.00 | 17% 3.36M to 3.94M | |
| 24-Apr-14 2:59 PM View: | Drant Ryan D Director 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Purchase Duplicate | 583,333 | $12.00 | $7,000,000.00 | 17% 3.36M to 3.94M | |
| 24-Apr-14 4:05 PM View: | Roeder Douglas A Director 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Purchase Duplicate | 833,333 | $12.00 | $10,000,000.00 | 7% 12.14M to 12.98M | |
| 23-Apr-14 6:11 PM View: | Scopa James Paul Director | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion | 1,776,690 | -- | -- | 40% 4.5M to 6.27M | |
| 24-Apr-14 2:58 PM View: | New Enterprise Associates 1... 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion | 3,359,940 | -- | -- | 100% 0 to 3.36M | |
| 24-Apr-14 4:04 PM View: | Delphi Management Partners ... 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion | 2,702,580 | -- | -- | 29% 9.44M to 12.14M | |
| 23-Apr-14 6:12 PM View: | Mpm Bioventures Iv Qp Lp 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion Duplicate | 1,776,690 | -- | -- | 40% 4.5M to 6.27M | |
| 24-Apr-14 4:05 PM View: | Roeder Douglas A Director 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion Duplicate | 2,702,580 | -- | -- | 29% 9.44M to 12.14M | |
| 22-Apr-14 5:16 PM View: | Flynn James E 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Conversion | 632,669 | -- | -- | 100% 0 to 632.67K | |
| 24-Apr-14 4:04 PM View: | Delphi Management Partners ... 10% Owner | Trivascular Technologies, I... (TRIV) | 22-Apr-14 | Purchase | 833,333 | $12.00 | $10,000,000.00 | 7% 12.14M to 12.98M |
